Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Pneumococcal infections in elderly patients attending hospital since PCV-13 authorization in Spain.

Payeras A, Peñaranda M, Iñigo A, Garau M, Luis Pérez J, Gallegos C, Riera M.

Infect Dis (Lond). 2017 Jan;49(1):71-80.

PMID:
27686179
2.

Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013.

Sobrino-Vegas P, Moreno S, Rubio R, Viciana P, Bernardino JI, Blanco JR, Bernal E, Asensi V, Pulido F, del Amo J, Hernando V; Cohorte de la Red de Investigación en Sida, Spain..

J Infect. 2016 May;72(5):587-96. doi: 10.1016/j.jinf.2016.01.017.

3.

The Burden of Neglected HIV-2 and HTLV-1 Infections in Spain.

Treviño A, Caballero E, de Mendoza C, Aguilera A, Pirón M, Soriano V; Spanish HIV-2/HTLV Study Group..

AIDS Rev. 2015 Oct-Dec;17(4):212-9. Review.

PMID:
26616845
4.

Cyprinid Herpesvirus 3: An Archetype of Fish Alloherpesviruses.

Boutier M, Ronsmans M, Rakus K, Jazowiecka-Rakus J, Vancsok C, Morvan L, Peñaranda MM, Stone DM, Way K, van Beurden SJ, Davison AJ, Vanderplasschen A.

Adv Virus Res. 2015;93:161-256. doi: 10.1016/bs.aivir.2015.03.001. Review.

PMID:
26111587
5.

Relationships between Serum Levels of Atazanavir and Renal Toxicity or Lithiasis.

Marinescu CI, Leyes M, Ribas MA, Peñaranda M, Murillas J, Campins AA, Martin-Pena L, Barcelo B, Barceló-Campomar C, Grases F, Frontera G, Riera Jaume M.

AIDS Res Treat. 2015;2015:106954. doi: 10.1155/2015/106954.

6.

Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions.

Sobrino-Vegas P, Monge Corella S, Serrano-Villar S, Gutiérrez F, Blanco JR, Santos I, del Romero J, Segura F, Portilla J, Guillén SM, del Amo J; CoRIS..

PLoS One. 2014 Dec 30;9(12):e116226. doi: 10.1371/journal.pone.0116226.

7.

Shorter telomere length predicts poorer immunological recovery in virologically suppressed HIV-1-infected patients treated with combined antiretroviral therapy.

Blanco JR, Jarrin I, Martinez A, Siles E, Larrayoz IM, Cañuelo A, Gutierrez F, Gonzalez-Garcia J, Vidal F, Moreno S; CoRIS-Biobanco..

J Acquir Immune Defic Syndr. 2015 Jan 1;68(1):21-9. doi: 10.1097/QAI.0000000000000398.

PMID:
25321176
8.

HIV-2 and HTLV-1 infections in Spain, a non-endemic region.

de Mendoza C, Caballero E, Aguilera A, Pirón M, Ortiz de Lejarazu R, Rodríguez C, Cabezas T, González R, Treviño A, Soriano V; Spanish HIV-2/HTLV Group..

AIDS Rev. 2014 Jul-Sep;16(3):152-9. Review.

PMID:
25180694
9.

World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Review Team., LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, Peñaranda MM, Ramos JF, Sarin S, Stimac D, Thomson AB, Umar M, Krabshuis J, LeMair A; World Gastroenterology Organisation..

J Clin Gastroenterol. 2014 Jul;48(6):467-73. doi: 10.1097/MCG.0000000000000116. No abstract available.

PMID:
24921212
10.

Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes.

Monge S, Diez M, Pulido F, Iribarren JA, Campins AA, Arazo P, Montero M, Miro JM, Moreno S, Del Amo J; Spanish AIDS Research Network Cohort (CoRIS)..

Int J Tuberc Lung Dis. 2014 Jun;18(6):700-8. doi: 10.5588/ijtld.13.0778.

PMID:
24903942
11.

['Third day intervention': an analysis of the factors associated with following the recommendations on the prescribing of antibiotics].

García-San Miguel L, Cobo J, Martínez JA, Arnau JM, Murillas J, Peña C, Segura F, Gurguí M, Gálvez J, Giménez M, Gudiol F; Grupo REIPI..

Enferm Infecc Microbiol Clin. 2014 Dec;32(10):654-61. doi: 10.1016/j.eimc.2013.09.021. Spanish.

PMID:
24813928
12.

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.

Treviño A, Soriano V, Poveda E, Parra P, Cabezas T, Caballero E, Roc L, Rodríguez C, Eiros JM, Lopez M, De Mendoza C; HIV-2 Spanish Study Group..

J Antimicrob Chemother. 2014 Aug;69(8):2191-4. doi: 10.1093/jac/dku119.

PMID:
24788659
13.

Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations.

Monge S, Guillot V, Alvarez M, Chueca N, Stella N, Peña A, Delgado R, Córdoba J, Aguilera A, Vidal C, García F; CoRIS..

PLoS One. 2014 Mar 17;9(3):e90710. doi: 10.1371/journal.pone.0090710.

14.

[Eczema coxsackium (Coxsackievirus A6) in an human immunodeficiency virus infected adult patient].

Reina J, Peñaranda M, Cabrerizo M.

Rev Clin Esp (Barc). 2014 May;214(4):228-9. doi: 10.1016/j.rce.2014.01.006. Spanish. No abstract available.

PMID:
24508220
15.

Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group.

Curran A, Monteiro P, Domingo P, Villar J, Imaz A, Martínez E, Fernández I, Knobel H, Podzamczer D, Iribarren JA, Peñaranda M, Crespo M; PIMOCS Study Group..

J Antimicrob Chemother. 2014 May;69(5):1390-6. doi: 10.1093/jac/dkt517.

PMID:
24415645
16.

[Infections due to human immunodeficiency virus type 2 and human T-lymphotropic viruses in Spain].

Treviño A, Soriano V; Grupo Español para el Estudio del VIH-2 y HTLV..

Med Clin (Barc). 2014 Apr 7;142(7):323-6. doi: 10.1016/j.medcli.2013.06.009. Spanish. No abstract available.

PMID:
24012445
17.

Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort.

Suárez-García I, Sobrino-Vegas P, Tejada A, Viciana P, Ribas M, Iribarren J, Díaz Menéndez M, Rivero M, Arazo P, Del Amo J, Moreno S; Cohort of the Spanish AIDS Research Network (CoRIS) study group..

HIV Med. 2014 Feb;15(2):86-97. doi: 10.1111/hiv.12078.

18.

All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010.

Hernando V, Alejos B, Monge S, Berenguer J, Anta L, Vinuesa D, Palacios R, Muga R, Moreno S, Jarrin I; CoRIS cohort..

BMC Infect Dis. 2013 Aug 20;13:382. doi: 10.1186/1471-2334-13-382.

19.

Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain.

Monge S, Alejos B, Dronda F, Del Romero J, Iribarren JA, Pulido F, Rubio R, Miró JM, Gutierrez F, Del Amo J; CoRIS..

HIV Med. 2013 May;14(5):273-83. doi: 10.1111/hiv.12001. Erratum in: HIV Med. 2014 Jan;15(1):64.

20.

Analysis of transmitted drug resistance in Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside drug class.

Monge S, Guillot V, Alvarez M, Peña A, Viciana P, García-Bujalance S, Pérez Elias MJ, Iribarren JA, Gutiérrez F, Itziar Casado M, Garcia F; CoRIS..

Clin Microbiol Infect. 2012 Nov;18(11):E485-90. doi: 10.1111/1469-0691.12011.

Items per page

Supplemental Content

Loading ...
Support Center